Patrick Mismetti

Inserm — France

Medicine · Health Sciences

41h-index12.1kcitations208works8.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(125), Atrial Fibrillation Management and Outcomes(78), Central Venous Catheters and Hemodialysis(18), Heparin-Induced Thrombocytopenia and Thrombosis(18), Diagnosis and Treatment of Venous Diseases(17)

Publications200 total

Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
The Lancet Haematology·2025· 1 cited
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study
Thrombosis and Haemostasis·2025
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism, including by cancer site: Post-hoc analysis of the API-CAT randomised trial
Blood·2025
The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group
Archives of cardiovascular diseases·2025Open Access
Anticoagulant management in Emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP), endorsed by the French Neurovascular Society
Anaesthesia Critical Care & Pain Medicine·2025· 1 cited
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
The Lancet·2025· 57 citedOpen Access
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
Anaesthesia Critical Care & Pain Medicine·2024· 7 citedOpen Access
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study
Journal of Thrombosis and Haemostasis·2024· 4 citedOpen Access
Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice
Current Research in Translational Medicine·2023· 5 cited
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with venous thromboembolism in the nationalFrench hospital discharge database
Research Square (Research Square)·2022Open Access
Recovery from acute kidney injury in patients with pulmonary embolism: A monocenter study
JMV-Journal de Médecine Vasculaire·2022
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
American Journal of Cardiovascular Drugs·2021Open Access
Management of acute venous thromboembolism in patients taking antiplatelet therapy
Thrombosis Research·2021· 6 cited
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism
CHEST Journal·2021· 142 cited
Prise en charge des patients, sous antiagrégation plaquettaire, présentant une maladie thromboembolique veineuse
JMV-Journal de Médecine Vasculaire·2021
Early Venous Thromboembolism Is A Strong Prognostic Factor In Patients With Advanced Pancreatic Ductal Adenocarcinoma
Research Square (Research Square)·2021Open Access
Prevention of Venous Thromboembolic Events in Patients with Lower Leg Immobilization after Trauma: Systematic Review and Network Meta-Analysis with Meta-Epidemiological Approach
SSRN Electronic Journal·2021Open Access
Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis
Thrombosis Research·2020· 23 cited
Comparaison du bénéfice-risque à trois ans du dabigatran versus rivaroxaban, en fonction de la dose standard ou réduite, dans la fibrillation auriculaire non-valvulaire, cohorte ENGEL 2 à partir des données du Système national des données de santé avec appariement sur un score de propension haute dimension
Revue d Épidémiologie et de Santé Publique·2020
Association between initial and residual pulmonary vascular obstruction and pulmonary embolism recurrence, a pooled analysis
Revue d Épidémiologie et de Santé Publique·2020
page 1 of 10Next →

Frequent Co-authors

Silvy Laporte(19), Hervé Decousus(10), Laurent Bertoletti(8), Paul Zufferey(6), Charles Marc Samama(6), Gilles Pernod(6), Nadia Rosencher(6), Guy Meyer(6), Sara Quenet(6), Michel Cucherat(5), Isabelle Mahé(5), Sam Schulman(4), Clive Kearon(4), Ajay K. Kakkar(4), H Decousus(4), Serge Molliex(4), Pierre Albaladejo(4), Piérre Siè(4), Antoine Élias(4), Benjamin Planquette(4)